Pharmaceutical & medical
future technologies for managing drug delivery for quality validation and reproducibility. Amongst these are microneedles, which are, essentially, miniaturised needles offering more effective drug delivery with less pain. There are different types including dissolvable microneedles which, as their name suggests, dissolve following insertion into the skin and release of the drug enclosed within them. OOAC microfluidic devices are evolving
rapidly and present exciting opportunities across the drug discovery pipeline from candidate identification to efficacy, toxicity and safety. These microscale in vitro human physiological models are efficient and cost- effective with their added potential to reduce the use of animal models offering an ethical alternative to conventional pre-clinical drug discovery approaches. Moreover, OOAC technology can be used as implantable drug delivery devices capable of producing continuous, non-continuous or pulsatile delivery patterns by less painful means. Fluid flow measurement has an integral role to play in the translational journey of these novel microfluidic applications from bench to clinic. For example, the interconnection by microfluidic flow of single organ models enabling the study of biological interactions between organs. The burgeoning adoption of technologies
these devices and examining the influence of fast-changing flow rates and innovative approaches to make these challenging measurements, for example, optical methods. The research programme will also
investigate how mixtures of liquids with different viscosities mix and flow in multi- infusion systems and how this affects the therapeutic drug concentration over the course of an infusion. It is intended that such rigorous metrology will prevent harm to patients arising from inappropriate mixing such as therapeutic failure or toxicity. The primary infusion devices used for
administration have a significant impact on metrology. In the case of intravenous administration, for example, various devices with different purposes may be used (syringe pumps, peristaltic pumps, insulin pumps). Each method must be capable of delivering traceable, accurate and reproducible metered doses of drug. Understanding the sources of, and minimising, measurement uncertainties attributable to the operation of each device is key to achieving this and is a fundamental aspect of the work being undertaken in this multi-partner project where uncertainties of one to two per cent are being targeted. In addition to existing drug delivery devices,
the metrology infrastructure and standards arising from this project are also aimed at
Instrumentation Monthly January 2021 27
such as OOAC in healthcare will necessitate the development of a metrological infrastructure to validate their accuracy and reproducibility. Accordingly, a further aim of the collaborative European metrology project is the development of a proof-of-concept microfluidic microchip flow pump for use as a moveable traceable transfer standard for the calibration of drug delivery devices used in drug discovery and OOAC for ultra-low flow rates (below 100 nL/min).
Regulatory compliance underpins every
innovation or innovative methodology within the medical device sector; an obligation which is set to increase from May 2020 when the new Medical Devices Regulation (Regulation (EU) 2017/745) comes into full force. The increasing innovation and complexity of drug infusion systems will inevitably see metrological information form an essential part of the regulatory approval process for these medical devices. Their characteristically judicious approach will see regulators seeking to require device manufacturers to apply metrological standards at national, European and international level. Not only will this entail the development of
existing standards, it will require the creation of new ones to address their diversity and increasing complexity. Whilst at an embryonic stage, microfluidic technology is progressing apace. In parallel, work is needed to define measurement standards for microfluidic devices covering areas such as the control and quantification of fluid flows. Developing microfluidics measurement standards will facilitate their uptake across the pharmaceutical and health sectors by providing the necessary accuracy and reliability in their manufacture and performance. The advantages of microfluidic devices as
drug discovery and delivery platforms cannot be underestimated; they are quick, inexpensive, portable and effective. However, developing a robust flow metrology infrastructure to validate their quality, reduce dosing errors and ensure device efficacy and safety is key to unlocking their potential.
TÜV SÜD National Engineering Laboratory
www.tuvsud.com/en-gb/industries/chemical- and-process/flow-measurement
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74
